| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.6B | $1.5B | $1.4B | $1.3B | $1.1B | $1.5B | $1.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.8B | $0.8B | $0.7B | $0.6B | $0.5B | $0.8B | $0.8B |
| Net Income | $3.5B | $0.8B | $0.9B | $0.8B | $0.6B | $0.3B | $0.6B | $0.8B |
| EPS (Basic) | $9.35 | $2.04 | $2.29 | $2.06 | $1.53 | — | — | — |
| EPS (Diluted) | $9.35 | $2.04 | $2.29 | $2.06 | $1.53 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $40.6B | $32.4B | $34.3B | $33.0B | $33.8B | $34.8B | $31.2B | $30.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.8B | $1.4B | $1.2B | $0.6B | $0.5B | $1.0B | $0.7B | $0.5B |
| Total Liabilities | $33.9B | $28.8B | $30.6B | $29.2B | $29.4B | $31.1B | $28.1B | $26.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.2B | $2.9B | $3.0B | $3.1B | $3.4B | $3.0B | $2.5B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.1B | $3.8B | $3.9B | $3.8B | $3.6B | $2.3B | $3.8B | $3.8B |
| Investing Cash Flow | $-1.6B | $1.4B | $-1.4B | $-0.6B | $-0.6B | $-4.0B | $-1.1B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-3.1B | $-5.0B | $-2.0B | $-3.1B | $-3.6B | $2.0B | $-2.6B | $-4.5B |